Pharmacokinetics of the Cardioprotective Drug Dexrazoxane and Its Active Metabolite ADR-925 with Focus on Cardiomyocytes and the Heart-Reference-Cited by-同舟云学术

Pharmacokinetics of the Cardioprotective Drug Dexrazoxane and Its Active Metabolite ADR-925 with Focus on Cardiomyocytes and the Heart

Published:2017-12-22 Issue:3 Volume:364 Page:433-446
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Jirkovský Eduard,Jirkovská Anna,Bureš Jan,Chládek Jaroslav,Lenčová Olga,Stariat Ján,Pokorná Zuzana,Karabanovich Galina,Roh Jaroslav,Brázdová Petra,Šimůnek Tomáš,Kovaříková Petra,Štěrba Martin

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference53 articles.

1. In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity

2. Metal ion-promoted hydrolysis of the antioxidant cardioprotective agent dexrazoxane (ICRF-187) and its one-ring open hydrolysis products to its metal-chelating active form

3. Ferrous Ion Strongly Promotes the Ring Opening of the Hydrolysis Intermediates of the Antioxidant Cardioprotective Agent Dexrazoxane (ICRF-187)

4. Dexrazoxane

5. Pharmacokinetics of (+)-1,2-di(3,5-dioxopiperazin-1-yl)propane intravenous infusions in adult cancer patients;Earhart;Cancer Res,1982

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review;Current Treatment Options in Oncology;2024-07-27

2. Ironing out Persisters? Revisiting the Iron Chelation Strategy to Target Planktonic Bacterial Persisters Harboured in Carbapenem-Resistant Escherichia coli;Microorganisms;2024-05-12

3. Extracellular vesicles derived from HuMSCs alleviate daunorubicin-induced cardiac microvascular injury via miR-186-5p/PARP9/STAT1 signal pathway;Regenerative Therapy;2024-03

4. Dexrazoxane does not mitigate early vascular toxicity induced by doxorubicin in mice;PLOS ONE;2023-11-28

5. In vitro to clinical translation of combinatorial effects of doxorubicin and dexrazoxane in breast cancer: a mechanism-based pharmacokinetic/pharmacodynamic modeling approach;Frontiers in Pharmacology;2023-10-19